博瑞医药: 第四届监事会第九次会议决议公告

Group 1 - The company held its 9th meeting of the 4th Supervisory Board on August 28, 2025, with all 5 supervisors present, confirming compliance with legal and regulatory requirements [1][2] - The Supervisory Board approved the 2025 semi-annual report, affirming that it accurately reflects the company's operational status for the first half of 2025 and adheres to relevant laws and regulations [1][2] - The Supervisory Board also approved the special report on the use of raised funds, confirming that the company has strictly followed regulations regarding the storage and use of these funds, with no violations reported [2][3] Group 2 - The company prepared a revised report on the previous use of raised funds as of June 30, 2025, which was verified by a certified public accountant [2]